Lidocaine Kade (Lidocaine)

Lidocaine is a local anesthetic used to block nerve conduction in the rectal mucosa.

• Rectal procedures: Provides localized anesthesia to facilitate minor surgical or diagnostic interventions in the rectal area.
• Rectal pain: Relieves discomfort associated with conditions such as hemorrhoids, fissures, or post‑procedural soreness.
• Diagnostic examinations: Reduces sensation during anoscopy or sigmoidoscopy to improve patient tolerance.

• Lidocaine blocks voltage‑gated sodium channels on neuronal membranes, preventing the rapid influx of sodium ions required for depolarization. By inhibiting initiation and propagation of nerve impulses, it produces reversible loss of sensation in the targeted tissue without affecting surrounding structures.

Lidocaine may cause a range of adverse reactions, from mild local irritation to rare systemic toxicity.

Common Side Effects

• Burning or stinging at the application site.
• Localized numbness extending beyond the intended area.
• Mild erythema or swelling of the rectal mucosa.
• Transient headache or dizziness.

Serious or Rare Side Effects

• Allergic reaction including rash, pruritus, or angioedema.
• Systemic toxicity presenting as seizures, cardiac arrhythmias, or hypotension.
• Methemoglobinemia leading to cyanosis.
• Severe hypotension or cardiovascular collapse.

When using Lidocaine Kade, clinicians should observe several safety measures.

• Assess allergy: Verify the patient has no known hypersensitivity to amide‑type local anesthetics.
• Limit dose: Use only the amount prescribed to avoid systemic toxicity.
• Monitor vital signs: Observe for signs of central nervous system or cardiovascular effects during and after administration.
• Avoid on compromised mucosa: Do not apply to inflamed or ulcerated rectal tissue unless specifically directed.
• Pregnancy and lactation: Use only if the expected benefit justifies the potential risk after professional assessment.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lidocaine can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

• Class I antiarrhythmics (e.g., quinidine, procainamide): may increase lidocaine plasma concentrations.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise systemic exposure.
• Concurrent use of other local anesthetics: additive toxicity risk.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may potentiate lidocaine’s cardiac depressant effects.
• Diuretics: may enhance the risk of hypotension when combined with lidocaine.